| abstract |
Compounds are provided that are inhibitors of both rhokinase and monoamine transporter (MAT) that act to ameliorate the disease state or condition. Further provided are compositions comprising the present compounds. Further provided is a method of treating a disease or condition comprising administering a compound according to the present invention. One such disease may be glaucoma that can achieve a significant reduction in intraocular pressure (IOP), among other beneficial effects. |